Statins impair glucose uptake in human cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: Considering the increasing number of clinical observations indicating hyperglycemic effects of statins, this study was designed to measure the influence of statins on the uptake of glucose analogs by human cells derived from liver, adipose tissue, and skeletal muscle. Design: Flow cytometry and scintillation counting were used to measure the uptake of fluorescently labeled or tritiated glucose analogs by differentiated visceral preadipocytes, skeletal muscle cells, skeletal muscle myoblasts, and contact-inhibited human hepatocellular carcinoma cells. A bioinformatics approach was used to predict the structure of human glucose transporter 1 (GLUT1) and to identify the presence of putative cholesterol-binding (cholesterol recognition/interaction amino acid consensus (CRAC)) motifs within this transporter. Mutagenesis of CRAC motifs in SLC2A1 gene and limited proteolysis of membrane GLUT1 were used to determine the molecular effects of statins. Results: Statins significantly inhibit the uptake of glucose analogs in all cell types. Similar effects are induced by methyl-β-cyclodextrin, which removes membrane cholesterol. Statin effects can be rescued by addition of mevalonic acid, or supplementation with exogenous cholesterol. Limited proteolysis of GLUT1 and mutagenesis of CRAC motifs revealed that statins induce conformational changes in GLUTs. Conclusions: Statins impair glucose uptake by cells involved in regulation of glucose homeostasis by inducing cholesterol-dependent conformational changes in GLUTs. This molecular mechanism might explain hyperglycemic effects of statins observed in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Mohanty, J. G., Jaffe, J. S., Schulman, E. S., & Raible, D. G. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00244-x · Cited by 496 · cited 1×
“published methodology.(19) 20 Reactions were composed of 50 μM Amplex Red reagent, 0.”
MethodStatin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative
Culver, A. L. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.625 · Cited by 444 · cited 1×
“7-fold higher risk of type 2 diabetes mellitus.(5) These observations are at odds with a previous primary prevention statin trial (WOSCOPS), where 30% lower incidence of diabetes was found in patients taking pravastatin,(6) as well as with the results of the ATOROS study in which no changes in the glycemic control wer…”
ResultEffect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D., Sachdeva, R., Kesan, S. H., & Mehta, J. L. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318197ec8b · Cited by 126
Cited by
Statin Toxicity: Mechanistic Insights and Clinical Implications
Ward, N. C., Watts, G. F., & Eckel, R. H. (2019) · Circulation Research · doi:10.1161/circresaha.118.312782 · Cited by 757
Lipid–Protein Interactions Are Unique Fingerprints for Membrane Proteins
Corradi, V., Mendez-Villuendas, E., Ingólfsson, H. I., Gu, R.-X., Siuda, I., Melo, M. N., Moussatova, A., DeGagné, L. J., Sejdiu, B. I., Singh, G., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00143 · Cited by 358
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82
Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical Phospholipids
Hresko, R. C., Kraft, T. E., Quigley, A., Carpenter, E. P., & Hruz, P. W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730168 · Cited by 67
VEGF‐B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content
Moessinger, C., Nilsson, I., Muhl, L., Zeitelhofer, M., Heller Sahlgren, B., Skogsberg, J., & Eriksson, U. (2020) · The EMBO Reports · doi:10.15252/embr.201949343 · Cited by 42
Metadata
- Authors
- Nowis, D., Malenda, A., Furs, K., Oleszczak, B., Sadowski, R., Chlebowska, J., Firczuk, M., Bujnicki, J. M., Staruch, A. D., Zagozdzon, R., Glodkowska-Mrowka, E., Szablewski, L., & Golab, J.
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2014-04
- Volume
- 2
- Issue
- 1
- Pages
- e000017
- ISSN
- 2052-4897 (ISSN-L)
- OpenAlex
- W2029494606
- Cited by
- 45
- References
- 4
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statins impair glucose uptake in human cells. https://app.cochat.ai/papers/10.1136/bmjdrc-2014-000017
- The paper
- Nowis, D., Malenda, A., Furs, K., Oleszczak, B., Sadowski, R., Chlebowska, J., Firczuk, M., Bujnicki, J. M., Staruch, A. D., Zagozdzon, R., Glodkowska-Mrowka, E., Szablewski, L., & Golab, J. (2014). Statins impair glucose uptake in human cells. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2014-000017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.